← Open Payments lookup

IFEOMA NWOSU: Open Payments

NPI 1518380781 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$522 in 23 payments from 8 companies in 2025. Trend: 2023 $539 · 2024 $750 · 2025 $522

Food & beverage: $522
CompanyPaymentsAmount
Exact Sciences Corporation5$204
Amgen Inc.5$83
Novo Nordisk Inc3$68
Bayer Healthcare Pharmaceuticals Inc.2$41
Boehringer Ingelheim Pharmaceuticals, Inc.2$33
AstraZeneca Pharmaceuticals LP2$31
Cumberland Pharmaceuticals, Inc.2$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$30

Products named: Cologuard Collection Kit, OTEZLA, Ozempic, Kerendia, REPATHA, JARDIANCE, KRISTALOSE, XIFAXAN.

Industry payments across TX — which companies pay providers there.